Haier Biomedical SDD Vaccine Refrigerators Successfully Shipped to Cameroon for the CCEOP Vaccine Program

Last week, the Cameroon CCEOP project cooperated by Haier Biomedical and UN reached a major milestone. 20 containers of SDD vaccine refrigerators have been successfully shipped and will be used in the Cameroon local vaccine initiative. After the products arrive, Haier Biomedical's local service provider will provide localized services to ensure the project achieved. The local partner is a one-stop service covering transportation, installation, device commissioning, product training and after-sales service to solve any last mile issues for users. This service ensures users don’t need to worry about long distances, complicated road conditions, changeable installation environment, all work from delivery to installation is provided by Haier Biomedical’s local partners – end users have no concerns.

click to check the video of the program

The Haier Biomedical Solar Direct Drive (SDD) vaccine refrigerators supplied are specifically designed for remote areas in Africa, and all have been certified by WHO/PQS, with direct solar power to solve the obstacles of any local electric supply shortages. The application of microprocessor temperature control system ensures superior temperature uniformity, and the temperature can be checked remotely and in real time. In addition, the temperature can be maintained under 8℃ for about 5 days after power outage, and Grade A reeze-protection technology protects the stability of the inside temperature which keeps the vaccines safe.

Demonstrating Powerful Local Service Capabilities, Haier Biomedical CCEOP Team Delivers on Time & Budget - Again!

As a long-term manufacturer and supplier to the CCEOP program, Haier Biomedical started the cooperation with the CCEOP initiative in 2016 with significant strong growth since 2018. In terms of project cooperation, Haier Biomedical has demonstrated its strong technological and service competitiveness and with expansion in the CCEOP market share from 0 to 27% within two years further growth is expected into 2021. Looking long term, Haier Biomedical will continue to develop regional resources based on the user-centric principle, this will be achieved by delivering solutions tailored to local conditions, again this is achieved through rich service experience in Africa by generated a strong localized service network. At present, Haier Biomedical has a large number of local coverage with the highest-level of service provider teams, having such a strong team ensures a win-win for all involved, especially those users working the hardest at the last mile.

Haier Biomedical, insisting on intelligent protection of life science and being empowered by technology, is committed to delivering the world’s leading sample and vaccine cold chain complete solutions!